Thromboxane A2 and prostaglandin F2α mediate inflammatory tachycardia

Abstract

Systemic inflammation induces various adaptive responses including tachycardia. Although inflammation-associated tachycardia has been thought to result from increased sympathetic discharge caused by inflammatory signals of the immune system, definitive proof has been lacking. Prostanoids, including prostaglandin (PG) D2, PGE2, PGF2α, PGI2 and thromboxane (TX) A2, exert their actions through specific receptors: DP, EP (EP1, EP2, EP3, EP4), FP, IP and TP, respectively. Here we have examined the roles of prostanoids in inflammatory tachycardia using mice that lack each of these receptors individually. The TXA2 analog I-BOP and PGF2α each increased the beating rate of the isolated atrium of wild-type mice in vitro through interaction with TP and FP receptors, respectively. The cytokine-induced increase in beating rate was markedly inhibited in atria from mice lacking either TP or FP receptors. The tachycardia induced in wild-type mice by injection of lipopolysaccharide (LPS) was greatly attenuated in TP-deficient or FP-deficient mice and was completely absent in mice lacking both TP and FP. The β-blocker propranolol did not block the LPS-induced increase in heart rate in wild-type animals. Our results show that inflammatory tachycardia is caused by a direct action on the heart of TXA2 and PGF2α formed under systemic inflammatory conditions.

DOI: 10.1038/nm1231

Statistics

01020'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

55 Citations

Semantic Scholar estimates that this publication has 55 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Takayama2005ThromboxaneAA, title={Thromboxane A2 and prostaglandin F2α mediate inflammatory tachycardia}, author={Koji Takayama and Koh-ichi Yuhki and Kyoichi Ono and Takayuki Fujino and Akiyoshi Hara and Takehiro Yamada and Shuhko Kuriyama and Hideji Karibe and Yuji Okada and Osamu Takahata and T. Taniguchi and Toshihiko Iijima and Hiroshi Iwasaki and Shuh Narumiya and Fumitaka Ushikubi}, journal={Nature Medicine}, year={2005}, volume={11}, pages={562-566} }